The Seattle Health Innovators Forum held its Holiday Party and Awards Night December 9, 2015 at the SURF Incubator in the Wells Fargo Center, attended by about 70 participants. This event brought a festive conclusion to an eventful year in the health innovation community in Western Washington. The community of innovators here is local but the innovations we are working on are often global in scale.
The Seattle Health Innovators Forum began in May of 2013, growing from a hotbed of health startups in and around Seattle. Its leadership consists of committees of volunteers who organize an average of 6 forums a year and other projects. Our 2015 forums included topics such as telehealth, the health regulatory climate, population health, precision medicine, measuring the impact of Seattle’s health innovation economy, and the Health Innovators Awards Night. Our membership of nearly 1000 people includes healthcare professionals, entrepreneurs, investors, product developers, freelancers, and others interested in the transformation of health and health care.
The 2015 Health Innovator of the Year Awards Program
2015 is the first year for this program. We announced a “Call for Nominations” in November aimed at grass-roots innovators, individuals who are active within startups, non-profits, payers, and health institutions. We identified 4 attributes of successful innovation: Imagination, Customer-centeredness, Perseverance, and Collaboration.
We received a strong response to the call, with over 35 nomination forms received in less than 4 weeks for a panel of high-quality nominees. We convened an team of respected health innovation professionals to review the nomination forms and select two awardees for each category.
Awardees for the Imagination Category
The Health Innovators of the Year for the Imagination category were awarded to Jeremy Stone, MD and Swatee Surve.
Jeremy Stone MD, MBA
Dr. Jeremy Stone is a Seattle-based physician entrepreneur with deep experience in the financial sector. He is pioneering a new approach to financing healthcare improvements, such as processes to improve post-operative wound care. He has applied a financial instrument, a performance based bond, to the healthcare sector. These “Health Innovation Bonds” can be used to securitize health outcomes. He has assembled a unique team and global advisors for this innovation. Dr. Stone was in London during the Awards ceremony and was represented by Mark Gardiner to receive the award.
Swatee Surve, MBA
Swatee Surve is the Founder and CEO of Litesprite. This is an innovative approach to mental health using games to kindly teach people skills that they can use to deal with stress, depression, and anxiety. Swatee also organized the recent Healthcare track of the Seattle Startup Week, the first time such a track has been part of this annual tradition. Swatee is a frequent panelist on such topics as behavioral health and women in technology leadership, and holds several patents on the disposition of electric currents on fibers and other materials.
Awardees for the Customer-centered Category
Our emphasis in the Customer-Centered category was for people who develop deep relationships with their customers so that they can understand their problems and develop predictive insights as to what their needs are. The Health Innovators of the Year for the Customer Centered category were awarded to Houda Hashad and J.W. Beard MD.
Houda Hachad, PharmD
Houda Hachad is the Chief Science Officer at Translational Software, whose customers are clinical labs who do pharmacogenomic ((PGx) testing. One of her nominators is a customer who said this of her: “Her deep knowledge of not only the clinical aspects of PGx testing, but also the molecular underpinnings of the assays was paramount in guiding our efforts. It is very rare in our business that one can find an individual who has mastered both aspects pertaining to molecular medicine. Furthermore, her understanding of which molecular markers were on the horizon in terms of clinical utility allowed us to shape our existing menu and plan for future tests. Houda’s expertise in pharmacogenetics and pharmacology is complimented by her ability to clearly communicate the important issues pertaining to these complex fields and eloquently answer difficult questions. From a customer support perspective, she has always made herself available at critical moments, to the point where we consider her as an extended team member.”
J.W. Beard, MD
JW Beard MD is a practicing Anesthesiologist and is the Founder and CEO of Monitor Mask Inc. As an anesthesiologist he knows first-hand about frustrations of others in his field when having to jerry-rig 20M basic oxygen face masks to provide a means for sampling the patients’ exhaled CO2 during sedation anesthesia. This vital measurement is mandated by the Standards of Care in the USA, Canada and UK but the market has simply not provided a suitable solution. He designed, tested, patented, and has successfully brought to market a new face mask for this important measurement, It is currently marketed as the CapnoVue M1 face mask.
Awardees for the Collaboration Category
Our emphasis for the Collaboration category this year was inter-organizational collaboration. One of the reasons health innovation is so difficult is that it takes innovators working within established organizations to reach out across organizational boundaries to solve important health problems. The 2015 Health Innovators of the Year for the Collaboration category were awarded to Col. David McCune MD and to Steven Friend, MD PhD.
Col David McCune, MD
Col. David McCune MD is a research consultant with the Western Region Medical Command (WRMC) with the US Army. He has been an effective spokesperson to increase public awareness of the Army’s clinical research program. He is focused on the quantity and quality of clinical trials which advance the health of US soldiers, spouses, dependents, and retirees. In 2015 Dr. McCune has appeared at multiple forums by the Washington Biotechnical and Biomedical Association and the Cambia Grove to inform the health innovation community of the research needs of these populations. He then followed up to help connect selected innovative Seattle area health startups with related research opportunities.
Steven Friend, MD PhD
Steven Friend MD PhD the founder of Sage Bionetworks, a Seattle-based non-profit organization founded in 2009, that provides the tools and environment to conduct dynamic, large-scale biomedical research transparently and collaboratively. In 2015 he led an effort to create an open ecosystem for health data acquired via mobile apps. Working jointly with Apple and Sage, Stephen led efforts that resulted in the open-source Research Kit (Apple) and Bridge / Synapse (Sage) technology platforms, and in the launch of an initial set of 5 Research Kit apps in Parkinson Disease (Sage), Breast Cancer (Sage), Asthma (Mt Sinai School of Medicine), Diabetes (Mass General Hospital), and Cardiovascular Disease (Stanford). As part of this effort, Stephen worked to coordinate a diverse set of collaborators across a variety of organizations, often putting the interests of other organizations ahead of his own. Dr. Friend was unable to attend the Awards night due to illness and was represented by Mike Kellen PhD, from Sage Bionetworks.
Awardees for the Perseverance Category
Innovating in the health industry is not for the impatient. It takes years to develop a solution and bring it to market. Entrepreneurs and other innovators in this sector must learn to deal with both successes and failures, technical and financial hardships, and the ups and downs from working through complex organizations. Some manage to do this with grace and as a result produce high quality output over time.The Health Innovators of the Year for the Perseverance category were awarded to Brandon Masterson and Mary Fenske.
Brandon Masterson is the Founder and CEO of 2Morrow Inc, a mobile health company offering behavior change programs for such conditions as smoking cessation and the creation of healthy habits. Founded in 2011, Brandon and his co-founder Jo Masterson mortgaged their home to self-fund this project for several years while they developed initial customers, won the Surgeon Generals design competition, and collaborated on the smoking cessation program with scientists at the Fred Hutchinson Institute. Brandon has the ability to take on complex problems that seem too hard, and break them into small chunks. This skill has been extremely useful during the startup phase of 2Morrow when challenges are common and resources are limited. It is easy to get discouraged. This makes Brandon an effective startup leader in the mHealth space, where the fast-moving tech industry meets the slower moving, more conservative healthcare industry. His general advice to others, and his company’s credo, is to have “big ears, thick skin and an open mind.”
Mary Fenske is the Founder of Posture Wings, a garment designed to place the body in good posture position with freedom of movement. This changes the biomechanics that can result in neck and shoulder pain. She designed, tested, patented this innovative garment and has persevered for 8 years to bring it to market. In 2006 she started work on this, was awarded a utility patent in 2011, She’s had lots of near-wins with licensing agreements and has continued to move forward despite these setbacks. She believes there remains a void in today’s market, even with the boom in wearable technology and continues to work towards a distribution deal through large scale retail and marketing organizations.
Special Recognition for “Up-and-Comers”
The Evaluation Committee for this year’s Health Innovators of the Year Awards worked through the weekend and into Tuesday evening to finalize the selection process. In the course of reviewing individual nomination forms a consensus grew around two nominees whose work in health innovation deserved an honorable mention for their fresh and creative approaches as, for lack of a better term, “Up-and-Comers”. These individuals are Corinne Pascale Stroum and Melissa DeCapua.
Corinne Pascale Stroum
Corinne is a Senior Program Manager at Caradigm on the Health Care Analytics Team. She is also the Founder of Oy, My Genes!, an innovative way for people to learn of disease risks discoverable through the 23andMe genetic test. When the FDA shut down 23andMe’s service to provide this information to consumers back in November 2013, Corinne developed and brought to market a website that allowed consumers with 23andMe credentials to submit them through her service so that consumers could still learn their risk factors for certain conditions relevant to Ashkenazi Jews. She is an active inventor and we expect to hear more from her in the coming years.
Melissa DeCapua, DNP, PMHNP
Dr. Melissa DeCapua is a board-certified psychiatric nurse practitioner. Her background includes child and adolescent psychiatry as well as psychosomatic medicine. Her nominator said of her “In February, she published a prophetic article describing seven novel ways that the Microsoft Hololens will transform healthcare from nursing education to disaster training. The article quickly caught fire on social media, pushing people to rethink the role of both patient and clinician in a future world where holographic technology more seamlessly bridges the gap to recovery. In March, she joined Seattle-based startup MedBridge as Healthcare Strategist and has since led a new product vision that combines patient data visualizations and educational interventions to improve patient outcomes. Melissa has served as Advisor for yet another fast-growing startup, Point Nurse. Melissa has done all of this and more while earning her Doctor of Nursing Practice in June and is continuing to be an active voice for healthcare reform through her Modern Nurse blog and guest posts on high-profile platforms like Microsoft in Health“.
The Making of “Seattle Health Innovators Holiday Party and Awards Night”
The event was made possible by a team of volunteers who have been working steadily to build a more supportive health innovation community in the Seattle area for the past few years.
A weekend strategy session in September 2015 was held with about 10 members of the program and research committees to plan future events and set goals for 2016.
Among the ideas to emerge from this session was to launch a Health Innovation Awards night. It would be based on a call for nominations from the community. Key themes were the need to broaden our scope to include projects connecting consumers, investors, and building partnerships. The Awards Program was conceived as a way to stimulate our audience beyond the forums, and to serve as a catalyst for developing deeper connections among the community members, Volunteering to head the effort to organize a Holiday Party and Awards Night was Chelsea Steinborn.
Chelsea served as the project manager for the event and as the master of ceremonies. Chelsea is a biomedical engineer, a recent UW Masters in Health Administration graduate, and is now a project manager with the Virginia Mason Research Institute. She played a leadership role in organizing three of our Health Innovation Forums in 2015. Joining Chelsea on the planning team for the Holiday Party were Grace Agustin, Ed Butler, and Kathryn Brown.
Grace Agustin is a Laboratory Information System manager at UW Medicine/Northwest Hospital and is active in Women in Bio and other community groups as well as the Seattle Health Innovators. She has provided support to many of our events. She was invited to join the Health Innovators program committee in 2015.
The 2015 Awards Evaluation Team
A team of experienced and impartial evaluators was formed to review the 2015 nominations. The following profiles provide a glimpse into the background of those who made the difficult evaluations leading to the 2015 awards. Each of the individuals on this team abstained from nominator and nominee roles for this year’s these awards.
Kathryn Brown, PharmD
Kathy Brown was an early and consistent member of the Seattle Health Innovators leadership group. She is a former VP of Pharmacy at Group Health, and is currently a Director of Pharmacy and Integrated Health at Premera and is a Clinical Assistant Professor at the University of Washington. She, along with Scott Kennedy organized the successful Population Health Management Forum in June 1015.
Ed Butler is the co-founder and CEO of Videris Health, a company focused on the needs of cancer patients. He is also is the founder of Agate Point. Ed, along with Jessica Chao, organized the Seattle Heatlh Innovation Forum meetup group in May 2013. Ed was formerly a senior product strategy manager at GE Healthcare, product strategy director and principal engineer at IDX Systems, and a former CIO for the Virginia Medicaid Program.
Brady Ryan is a Commercialization Manager for the Washington Biotechnology and Biomedical Association. Formerly he was a project manager for the WINGS angel investment group that focuses on the health and life sciences sector. Brady has been active in the Seattle Health Innovators since the summer of 2013 and has helped build bridges across the life sciences and health IT communities.
Scott Kennedy, CPA, CHFP
Scott Kennedy is a founding member of the Seattle Health Innovators and has been a consistent participant and member of the leadership team. Formerly an associate director of Finance with Group Health for 19 years, Scott now serves as Controller at the Polyclinic. Scott is also active in the Healthcare Financial Management Association. Scott and Kathy Brown organized the Seattle Health Innovators Population Health Management Forum last June.
Kristin Helps, RN
Kristin Helps is an active post anesthesia care nurse and regularly works shifts at several of Seattle’s hospitals while she completes her MS in Clinical Informatics from the UW. There she is doing research for user adoption of a mobile post surgery wound evaluation app. She is a clinical consultant with Wellpepper, a Seattle-based digital health startup. Kristin was elected to the UW graduate school student government representing 15,000 students in 2014.
John Foy, MD, PhD
John Foy is an independent senior level medical informatics consultant. His career in Medicine and Computer Science reaches back to the 1970s at NIH in the early days of electronic medical records. Dr. Foy has had an active role in the development of medical informatics over several decades especially as it pertains to electronic medical record systems. He was a director at IDX Systems (formerly PHAMIS) and continued as a senior product strategy manager upon the acquisition of IDX by GE in 2006 in such areas as critical care, clinical documentation, computerized physician order entry, and others. He was a founding member of the Seattle Health Innovation Forum in 2013 and has been a consistent participant and advisor ever since.
Also assisting in the Holiday Party event logistics were Eric Jain, Jo Masterson, Brian Crouch, and other volunteers. Thanks to Seaton and Candace Gras for their flexible terms in making the SURF venue available to this community. SURF has been a continuing supporter of this community since 2013.
More pictures from the Holiday Party and Awards Night
Mary Fenske accepting the Health Innovator of the Year Award for Perseverance.
Houda Hachad and JW Beard receive awards for the Customer Closeness category from Chelsea Steinborn.
Col. David McCune MD receives the Health Innovator of the Year Award for the Collaboration category, followed by Mike Kellen, PhD, nominator and representative of Steven Friend MD PhD.
Swatee Surve accepts Health Innovator of the Year Award for Imagination.
Brandon Masterson, explains how it’s done.
John Foy, on behalf of the evaluation team, surprises Ed Butler with a certificate recognizing his contributions to the Seattle Health Innovation Forum.
Pictured above, from left, are Mark Gardiner, accepting on behalf of Jeremy Stone MD, Brandon Masterson, Col David McCune MD, Mary Fenske, Swatee Surve, Houda Hachad PharmD, JW Beard MD, Mike Kellen PhD, on behalf of Steven Friend MD PhD, and Ed Butler, recognized for contributions to the growth of this forum.
This is the 4th in a series of posts comparing Seattle with other health innovation clusters. We are comparing several cities on a set of criteria of interest to healthcare startups. Katie Smolnycki is a life sciences market consultant who relocated to Seattle in early 2015 and has been a member of the Health Innovator research team. Her post below examines the institutions that can contribute to a vibrant ecosystem for health innovation companies.
By Katie Smolnycki
Continuing on our journey of exploring healthcare innovation hubs, we will examine the various healthcare institutions in Boston, Chicago, New York City, San Francisco, and Seattle. The comparison criteria in this series include the following:
- Cost of doing business – Seattle ranks in the middle.
- Financial capital – Seattle is lowest of the comparison cities in the amount invested in healthcare; 30% of angels are specifically associated with healthcare.
- Human capital –Highest ranked city in our study with the largest share of college grads[i]; hub for technology and sciences.
- Health Institutions- this post.
- Regional culture – to be posted in September.
To explore the institutions in each of these centers of interest, we decided to focus on hospitals, payers, NIH funding, and research institutions.
A competitive healthcare delivery market is favorable for innovators because these systems need to find ways to gain market share. How competitive is Seattle’s healthcare delivery market? To explore this we looked at the American Hospital Directory, which provides statistics for non-federal, short-term, and acute care hospitals in each state with data collected from each hospital’s most recent Medicare cost report[ii]. Compared with the other health innovation hubs, Seattle has the fewest hospitals and the lowest ratio of staffed beds. San Francisco and Boston have approximately the same number of hospitals and the most staffed beds per their population, with around 300 people per one staffed bed.
This suggests that the competitive pressures on Seattle’s hospital systems may be less intense than those cities with higher per capita beds. Concentration of ownership using the Herfindahl-Hirschman Index (HHI) is another method of assessing market competitiveness. The analysis below by David Cutler and Fiona Morton published in the Journal of the American Medical Association in 2013 compares the HHI across the US for hospital referral regions.
Seattle’s hospital referral region is moderately concentrated. This is similar to the markets in Boston, San Francisco, Chicago, and New York City. This suggests that the healthcare delivery market in Seattle is no more competitive, and is perhaps less competitive than the other hubs in our comparison set.
According to a study published by National Association of Insurance Commissioners (NAIC), the top large group insurance companies by market share (ranked largest to smallest) are: United Health Group, Wellpoint Inc. Group, Kaiser Foundation Group, Humana Group, Aetna Group, HCSC Group, Cigna Health Group, Highmark Group, Coventry Corp. Group, and HIP Insurance Group. At least one of top three large group insurers of NY, CA and IL all are represented in the NAIC Top Health Insurance Company report; whereas a main insurer for MA (BCBS of Mass) comes in at 23 and Cambia Health Solutions (the holding company for Regence BlueShield in WA, OR, UT, ID), comes in at 25. Seattle is not the headquarters of a single large national health insurance carrier. Our two Blue carriers, Premera, and Cambia Health Solutions, serve several western states but are not national entities. Group Health Cooperative is Washington-only.
Of the top 10 health insurance companies in the US, one is is headquartered in Chicago, two are in the Bay Area, and three are within commuting distance of the New York Metro area. This suggests that Seattle’s payer community may not have had the resources to provide a launchpad for startups, at least until recently.
Cambia Health Solutions is becoming an important player in the health innovation community in Seattle. Cambia Grove opened in the spring of 2015 providing a community space to bring innovators and entrepreneurs together with stakeholders to find innovative solutions from challenges in health care. They offer a variety of programming geared to helping entrepreneurs connect with the other players in the industry. One program hosted by Cambia Grove in July was a Reverse Pitch event which Evergreen Hospital pitched their problems to innovators in the digital health community.[iii].
NIH Research Funding
Funding of research grants by the NIH is an important part to furthering research in higher education centers, hospitals, and non-profits and for-profits research institutions. In FY2015, the NIH invested nearly $30.3 billion in medical research which allows investigators to come up with new ideas that can help change the world. This was $211 million above FY2014 budget, a 0.7% increase in funding, while FY2016 funding is expected to be $31.3 billion. The NIH main themes for driving discovery and innovation in FY 2015 funding were: today’s basic science for tomorrow’s breakthroughs, precision medicine, big opportunities in big data, and nurturing talent and innovation.
Boston received the most NIH research funding in both FY 2014 and 2015. Boston hospitals receive the most funding from the NIH for hospital research having five out of the top six top NIH funded hospitals[iv]. Hospital funding in Boston makes up almost 50% of the NIH funding received in the area. In the other regions, hospital based NIH funding makes up to 5% of the region’s NIH funds. For medical school NIH funding, NYC area schools (12 schools) receive $1.1 billion in research with Boston and Chicago medical schools (5 and 6 schools respectively) receiving over $400 million of medical school funding. Seattle only has one medical school but receives over $300 million in funding putting the University of Washington in the top five for funding in both FY 2014 and FY 2015.
Of the NIH funding that came to Washington in 2014, the University of Washington received $437 million, followed by Fred Hutch at $222 million, representing 75% of the total. This highlights the crucial importance of the UW and the Hutch in Seattle’s health innovation ecosystem. This ratio is similar to each of the other cities, looking at the top 50 organizations receiving NIH funding.
For more information on financial capital in these regions, please see our financial capital blog post
Life Science and Biotech Institutions
Washington State is home to 567 life science companies and research organizations with a majority of those located in the Greater Seattle area. There are 274 medical device companies, 182 biopharma companies and 92 nonprofit research organizations or academic research centers[v]. These companies combined add $11.4 billion to Washington’s GDP and represent the 5th largest employment sector, with a 12% growth in jobs from 2007 – 2013.
Out of the top 15 pharma companies by 2014 revenue[vi], Seattle is only has ties to three: Sanofi (some manufacturing), Gilead (inflammation/respiratory and hematology/oncology therapeutic areas and clinical research), and Bristol Myers Squibb (Zymogenetics ). In June 2015, Bristol Myers Squibb announced the relocation of the 40 Seattle based research and development jobs to San Francisco, leaving their early manufacturing group (approximately 120 employees) in Seattle[vii]. Amgen had a presence is Seattle until this past year when they closed down their facilities to cut costs. Seattle’s biotech sector is predominately small, early stage companies and some large nonprofit research institutions. For example Juno Therapeutics, an immunotherapeutics company, went public in December 2014 with $265 million IPO and a valuation of more than $3 billion. Juno recently announced a partnership with Celgene for $1 billion to work on the development and commercialization for immunotherapies[viii]. Presage Biosciences, an oncology start-up in Seattle that works to use human efficacy data earlier in drug development, announced August 20, 2015 that they received a strategic undisclosed investment from the venture capital arm of Takeda Pharmaceutical[ix]. About half of Washington’s life science companies are medical device companies, with Philips Healthcare being the largest medical device company located in the Greater Seattle area. Despite Seattle’s lack of large biopharma and medical device companies, there is still potential for collaboration with larger companies.
Seattle’s strong technology industry can help foster growth in the digital health space, as well as innovation in medical devices. In 2014, there was $1.1 billion in transactions across Washington State including IPOs, M&A activity, and venture equity and as of August 2015, there have been $2.5 billion in life science transactions, which is expected to reach $3 billion by the end of 2015. Transactions are approximately 38% medical technology, 31% pharmaceuticals, 23% health IT and 8% other[xi].
Boston, New York City, and San Francisco are home to many of the top biopharma and medical device companies (Johnson and Johnson, Novartis, Roche, Merck, GlaxoSmithKline, AstraZeneca, Bayer, Amgen, and Eli Lilly) and smaller startup companies as well. Chicago is home to fewer top healthcare companies than Boston, NYC, and the Bay Area but is headquarters for few larger companies, such as Abbott Laboratories (AbbVie), Baxter, Takeda (US headquarters), Walgreens, and Allscripts.
The presence of institutions with both the resources and the business drivers to innovate are favorable to health startups. Seattle’s position relative to the comparison cities is not as strong as it could be but still offers ample opportunities for health startups:
1. The healthcare delivery system market in Seattle is similarly concentrated as other cities but the per capita staffed bed ratio suggests that hospital systems here may still lack the existential competitiveness of other cities and may not yet be ready to look outside to the startup community for innovative approaches.
2. The health insurance industry in the Northwest has not been a national launchpad for startups.The recent activities of Cambia Health Solutions is a positive development.
3. NIH funding in Seattle lags Boston, New York, and San Francisco but is still respectable. This provides a critical funding stream and keeps Seattle in the running as an attractive location for health startups. This is mostly due to the influence of the UW and Fred Hutch in attracting federal research funds and spinning off new companies.
4. Seattle has a vibrant community of life sciences organizations that are not as large as those found in Boston and other life sciences hubs. The economic impact of this sector has been strong, with 12% job growth 2007-2013, as the 5th largest employment sector in the state.
By Angela Hong, June 29, 2015
This post is part of a series that compares Seattle with other cites using these criteria for what it takes for an area to become a health innovation hub:
- Cost of doing business / regulatory complexity
- Talent availability
- Financial capital
- Health institutions one might work with
- Regional culture / quality of life
Our last post compared the relative cost of doing business in Seattle. Seattle falls squarely in the middle compared to the other cities in our sample (Boston, Chicago, NYC, and SF). In this article, we’ll explore how Seattle fares in financial prowess.
In 2012, Seattle was ranked 9th in the top 10 best U.S. cities for business by ThinkAdvisor and also named the “29th most competitive city in the world.” In 2014, it jumped to 4th on Forbes‘ list of “best places to launch a startup.” While many factors make a city favorable to entrepreneurs looking to invest in new health products, financial capital is one of the most important. Its presence in Seattle is helping to make the city an up-and-coming hub for innovation, especially in the field of health.
Compared to other large cities, Seattle is becoming more well-known for its ability to draw ingenuity through financial capital. Exhibit A below shows that the number of angel investors in the city rival those of other major metropolitan areas: such as New York City, San Francisco, Chicago, and Boston. While New York and San Francisco currently outnumber most cities in local angels—at 1221 and 2163, respectively—Boston’s 397 seems reachable for Seattle. The Emerald City, as shown in this Angel List report, has 277 individuals who provide start-up capital for businesses, and this number is even greater than that of Chicago, which currently stands at 271.
This places Seattle in the running with major healthcare innovation hubs. And if the city’s number of investors begins to increase, a rise in healthcare-specific investors at the current rate would put Seattle level with well-established cities in terms of financial capital available for healthcare-related businesses.
Exhibit A: Angel Investor Comparison
Follow the Money
According to this Angel List data, eighty million dollars were invested by Seattle’s angels investing in health startups.This is lower than the other cities in our survey. The highest amount is spent in San Francisco at $1.04 billion and the second lowest is Chicago at $150 million.
Seattle: Financial Capital Overview
While Seattle has many fine qualities which make it an ideal business start-up city, it may not be thought of as a top health innovation hub in the way New York City, San Francisco, Boston, and Chicago are currently perceived. However, with rising numbers of angel investors interested in funding health-related businesses and the amount of financial capital for healthcare innovations already in motion, the city and its resources should be considered by those looking to make a difference in the medical field via creating new products, ideas, and business.
About the author
Angela Hong is a co-founder and CEO of Healthy Beeps She moved to Seattle from Boston in 2014 and is leading the Health Startup Location Attractiveness project.
The June 2, 2015 Seattle Health Innovation Meetup will focus on Population Health Management Innovation and will be held at the Cambia Grove in downtown Seattle from 5:30-8:00.
So what is Population Health Management (PHM), and how is innovation driving improvements in its practice?
PHM can be defined as managing the health outcomes of a group of individuals, where medical care is only one of many factors that affect those outcomes. Other factors include public health interventions, aspects of the social environment (income, education, employment, social support, and culture) and of the physical environment (urban design, clean air and water), genetics, and individual behavior.
At the provider level, the Care Continuum Alliance has proposed defining PHM as having three core components:
- Central care delivery and leadership roles of the primary care physician
- Critical importance of patient activation, involvement and personal responsibility
- Patient focus and capacity expansion of care coordination provided through wellness, disease and chronic care management programs.
The Institute for Health Technology Transformation (iHT2) outlines PHM principles and best practices as:
- Planning for population health
- Data collection, storage, and management
- Population monitoring and stratification
- Patient engagement
- Team-based interventions
- Outcomes measurement
5:30 – 6:00 Networking, food, refreshments
6:00 – 6:15 Community announcements
6:15 – 6:30 Key Note: PHM and Innovation
Speaker: Wellesley Chapman, MD, Group Health Medical Director, Innovation & Development
6:15 – 7:30 Moderated Panel discussion and audience Q&A
- Wellesley Chapman, MD, Group Health Medical Director, Innovation & Development
- Angela Marith, Group Health Director, Population Health Management
- Martin Levine, MD, Iora Primary Care Medical Director
- Shawn West, MD, Premera Medical Director of Provider Engagement
Topic: How is PHM being performed and what innovations, current or prospective, are needed to improve its practice?
7:30 – 8:00 Networking
We hope you can attend and we encourage you to bring your colleagues. There is a $10 registration fee to cover our costs for food and beverages (refundable up to 1 day before the event). Please RSVP at this link if you can attend, so that we can place the catering order. We look forward to seeing you at the Cambia Grove!
Population Health Management Innovation Forum Planning Team:
- Kathryn Brown
- Scott Kennedy
- Chelsea Steinborn
- Randy Wise
Angela Hong briefs the Seattle Telehealth Forum on the Location Attractiveness Survey, March 5 2015.
We, Angela Hong and Ed Butler, are co-founders of separate early-stage digital health startups and as a project of the Seattle Health Innovation meetup group, we are conducting a “location attractiveness” study to help determine where our new companies will be based. Yes, we love Seattle, but we want to be objective about it.
This is an exciting time to be in this field. The decision as to where to locate our early stage operations is not easy. We would like to take a systematic look at the most attractive metropolitan areas in the US for establishing and growing a new digital health startup. We have just begun this process and will provide updates via this blog on our progress. Where do you think the hottest health innovation cities are? We intend to find out.
With digital health investments reaching $4.1 billion in 2014, there is no question that the healthcare sector is ripe with opportunity. Unlike the glacial pace of change in health reimbursement and big-iron electronic health record systems, the 2014 spike in digital health investment is new and it is rapid. The top six categories, representing 44% of 2014 digital health investment are analytics/big data, healthcare consumer engagement, digital medical devices, telemedicine, personalized medicine, and population health management.
This study is being conducted from the standpoint of early stage digital health startup entrepreneurs. While we have worked within large healthcare organizations, consulting firms, and health IT vendors, we’ve learned to appreciate the difference between what is relevant for a big company and a startup. One of the first tasks we set for ourselves was to identify the criteria to use for assessing whether a city would be a good place to start a digital health venture.
Angela Hong, Chelsea Steinborn, Ed Butler at the Seattle Health Innovation Forum on Telehealth
The criteria we have decided to use to objectively assess different metro areas for suitability are as follows: regulatory environment, talent, financial capital, institutions and the regional culture.
Regulatory Environment: In order for entrepreneurs to want to incorporate or even set up shop in a particular location, the ease of forming the business is important. How hard and expensive is it to form a company? Are there any state or local laws that make it easier or harder to build a digital health product? Is this a location where we have to spend more of our precious startup funds on lawyers?
Talent: Startups cannot compete head to head with large companies on salaries, benefits, and, arguably, job security. It takes a certain mindset to offset the risks and low salaries of startups with the opportunities to work on something truly meaningful, and to have a chance of a windfall when the successful exit event occurs. It takes a certain population density to create a critical mass of skilled designers, engineers, health professionals, behavioral and life science researchers, marketing, sales professionals who are ready for this kind of a ride. Diversity is also crucially important in building cohesive and productive teams.
Financial Capital: Like most other types of startups, having access to financial capital whether it’s via venture capital or the angel community is extremely important. Unlike other industries, healthcare administration is inherently a harder industry to understand due to complex regulation and legacy institutions. The accessibility of investors whose investment strategies include the health industry is a rare resource and could make a difference in startup location attractiveness. It’s not just the money- we need savvy investors with whom we can gain market insights and key connections. Being 30 minutes away from a face to face meeting reduces friction and accelerates progress and accountability.
Institutions: Most healthcare startups need to form development partnerships and early adopter agreements with large health organizations for testing or piloting their product. Such institutions may include hospitals, payer organizations, pharmaceuticals, and life science research institutions. This is a big opportunity but also can be a pain point for many startups because of the predilections of too many institutional decision-makers to work only with “safe” name-brand corporate suppliers.
Regional Culture: Perhaps one of the more important criteria is a startup-friendly culture. Being in a location where startups thrive and can support each other can be a powerful advantage. How open and friendly is the startup culture in the metro area? Is it cut-throat competitive? How likely is it that other companies will poach your team? Typically startup entrepreneurs need help or advice when building their company and what better way to get help or advice if your neighbor sitting next to you at the coffee shop can provide that guidance. Quality of life for our teams is critical to being able to recruit the best people. Despite the hype around startups, it is not all about late night sprints and cold pizza. Living in a beautiful area with diverse cultural resources (museums, concerts, parks) and the ability to maintain a healthy lifestyle and to build relationships all contribute to building a sustainable team and an amazing company.
We are interested in what you think. What do you consider important when determining what city you want to live in? What do you think are the top health innovation cities in the US?
In terms of healthcare innovation hubs, cities such as San Francisco, Boston, Chicago or NYC typically come to mind but rarely does Seattle break into the top 5 names in the list. Why not? Seattle (and Portland) has access to world-class academic institutions, top tier human capital talent and major powerhouses in the technology industry. The 2014 Rock Health Funding Report shows surprising news that Portland-based Cambia Health was becoming a major player in digital health investment. Having access to financial capital definitely helps to fuel the healthcare startup community.
As part of Health Innovator’s 2015 initiative, we plan to analyze and understand how certain cities became healthcare innovation hubs and determine how to help Seattle become a health innovation center as well. Our goal is not to imitate what other cities have done but to understand how they got there and also figure out what Seattle’s unique formula for becoming a healthcare innovation hub.
Therefore, in our next few series of blog articles, we plan to benchmark other cities’ resources and determine what contributed to their healthcare innovation hub status and then map out the current Seattle resources. After our series of analyses, we will recommend a concrete strategy and action plan of how to help Seattle become a healthcare innovation hub.
We need all members of the Seattle health community to join us to put Seattle on the map as a healthcare innovation hub. Our belief is that this is not a solo task but instead we should rally everyone in the community (e.g. students in life sciences, government sponsors, big corporations and healthcare entrepreneurs). Please join us and make 2015 the year that we push healthcare to the forefront of Seattle’s attention.
Angela Hong is a healthcare entrepreneur and a Boston transplant to Seattle. She recently joined the Health Innovators Meetup and is excited to help Seattle become a healthcare innovation hub.